Purchase Order 75N96020P00366
Award Date 9/15/20
Potential Completion Date 11/13/20
Potential Value $54K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Kent, WA 98032, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), which is part of the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company headquartered in Canada with a registered entity in the United States. The $34,255.58 firm fixed-price contract is for the provision of media for the growth and maintenance of human pluripotent stem cells and induced pluripotent...
- This is a firm fixed-price delivery order for $47,405.00 awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company based in Canada. The contract is for a fully automated cell separator system called RoboSep, which automates the labeling and magnetic separation of cells, supporting the NIA's biomedical research activities. This contract is not...
- This is a federal contract award from the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company headquartered in Canada. The $7,131.73 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call for T-cell isolation products needed for research in Dr. Kemper's lab. Stemcell Technologies Inc. is a key supplier of advanced biological materials, laboratory...
- This is a firm fixed-price purchase order awarded by the Office of Logistics and Acquisition Operations, a civilian agency within the Department of Health and Human Services, to Stemcell Technologies Inc., a Canadian biotechnology company, to purchase a RoboSep-S automated cell separation system with a 5-year warranty and maintenance service. The contract, valued at $94,612.00, does not have a small business set-aside designation. Stemcell Technologies Inc. is a subsidiary of the Canadian parent...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), awarded a $45,760.35 firm-fixed-price purchase order contract to Stemcell Technologies Inc. on January 31, 2017. The contract is for an "Immunomagnetic Cell Separator" and had a completion date of February 28, 2017. Stemcell Technologies Inc. is a Canadian biotechnology company that specializes in cell culture media, cell separation systems, and...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $24,350.00 firm-fixed-price purchase order contract to Stemcell Technologies Inc., a foreign-owned, for-profit organization, for the provision of human cell enrichment kits. The contract has a completion date of May 31, 2019 and was awarded on May 15, 2018. This contract is not set aside for any specific business type. Stemcell Technologies Inc. is a...
- STEMCELL Technologies Inc., a subsidiary of the Canadian parent company STEMCELL Technologies, received a $11,943 firm fixed-price contract award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) on June 8, 2022. This was a Blanket Purchase Agreement (BPA) call representing a repeat order for specialized cell isolation and enrichment products, specifically an EasySep Human Pan-B Cell Enrichment Kit and custom human isolation kit components featuring CD86...
- This federal contract award to Stemcell Technologies Inc., a Canadian biotechnology company, is for the purchase of four RoboSep Limited Warranty units (Catalog # 20200, S/N RS-1232) at a total ceiling value of $14,970.00. The contract was awarded on February 16, 2012 by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS). The award does not have a set-aside designation. As a prime contractor, Stemcell...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS). The contract was awarded to Stemcell Technologies Inc., a Canadian biotechnology company that provides specialized cell culture media, cell separation systems, and other life sciences research products. The contract is for the provision of a RoboSep LTD warranty with a preventive maintenance package for a...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company headquartered in Canada. The $84,089.26 contract is for the provision of specialized biological materials, laboratory supplies, and scientific equipment to support biomedical research across various NIH institutes and centers, including the National Institute of Allergy and Infectious Diseases,...